Loading...
Evidence-based guidelines for managing patients with immune thrombocytopenia (ITP) were last presented by ASH in 2011. Now, a multidisciplinary panel has updated recommendations for contemporary management. Guidance was considered strong if the term “recommends” was used or conditional if the term “suggests” was used.
For newly diagnosed adults with minimal or no bleeding and platelet counts <30×109/L, the panel suggests corticosteroids versus observation.
For newly diagnosed adults with minimal or no bleeding and platelet counts <20×109/L, the panel suggests hospital admission.
For adults with established ITP, minimal or no bleeding, and platele…